Business Valuation Zone

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

companies novo-advisors

Paratek Pharmaceuticals to be Acquired by Gurnet Point Capital and Novo Holdings

Benzinga

JUNE 6, 2023

Under the terms of the merger agreement, Gurnet Point, a leading healthcare investment firm, and Novo Holdings, a holding and investment company responsible for managing the assets and wealth of the Novo Nordisk Foundation, will acquire all outstanding shares of Paratek for $2.15 per share in cash, plus a CVR of $0.85

Debt Financing

Debt Financing Finance Marketability

Second Leading Independent Proxy Advisory Firm Glass Lewis Recommends Paratek Pharmaceuticals Stockholders Vote FOR the Acquisition by Gurnet Point Capital and Novo Holdings A/S

Benzinga

SEPTEMBER 12, 2023

. ("Paratek") (NASDAQ: PRTK ), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel therapies for life-threatening diseases and other public health threats, today announced that a second leading independent proxy advisor Glass, Lewis & Co. Paratek Pharmaceuticals, Inc.

Marketability

Paratek Pharmaceuticals to be Acquired by Gurnet Point Capital and Novo Holdings

Second Leading Independent Proxy Advisory Firm Glass Lewis Recommends Paratek Pharmaceuticals Stockholders Vote FOR the Acquisition by Gurnet Point Capital and Novo Holdings A/S

Stay Connected